Edition:
United States

INSYS Therapeutics Inc (INSY.OQ)

INSY.OQ on NASDAQ Stock Exchange Global Market

15.65USD
29 Jul 2016
Change (% chg)

$0.01 (+0.06%)
Prev Close
$15.64
Open
$15.63
Day's High
$15.85
Day's Low
$15.38
Volume
74,639
Avg. Vol
209,433
52-wk High
$46.10
52-wk Low
$11.46

INSY.OQ

Chart for INSY.OQ

About

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. The Company's product Subsys, is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients and a single-use product that delivers fentanyl, an opioid... (more)

Overall

Beta: 1.98
Market Cap(Mil.): $1,118.99
Shares Outstanding(Mil.): 71.55
Dividend: --
Yield (%): --

Financials

  INSY.OQ Industry Sector
P/E (TTM): 22.45 41.55 39.69
EPS (TTM): 0.70 -- --
ROI: 23.72 -9.57 14.44
ROE: 24.34 -9.91 15.49

BRIEF-Insys Therapeutics announces FDA approval of Syndros

* Syndros is currently awaiting scheduling by U.S. Drug Enforcement Administration

Jul 05 2016

BRIEF-Two former Insys Therapeutics employees charged by U.S. in drug kickback scheme - StreetInsider, citing Bloomberg

* Two former Insys Therapeutics employees charged by U.S. in drug kickback scheme - StreetInsider, citing Bloomberg Source text - (http://bit.ly/1TZgVfy) Further company coverage: (Bengaluru Newsroom)

Jun 10 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Wright Reports
$75.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.